Abattis Bioceuticals Corp. Stock Canadian Securities Exchange
Equities
ATT
CA00258G1037
Healthcare Facilities & Services
Sales 2018 | 8.37K 6.13K | Sales 2019 | 357K 261K | Capitalization | 8.62M 6.31M |
---|---|---|---|---|---|
Net income 2018 | -78M -57.09M | Net income 2019 | -3M -2.2M | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 9.1M 6.66M | Net cash position 2019 | 2.25M 1.65M | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 19-03-31 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 18-10-18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Director of Finance/CFO | - | 19-03-31 |
1st Jan change | Capi. | |
---|---|---|
+27.84% | 272M | |
+28.81% | 269M | |
+48.84% | 200M | |
+38.04% | 134M | |
-41.00% | 124M | |
-28.57% | 121M | |
+115.91% | 120M | |
+150.00% | 75.33M | |
-3.85% | 66.62M |